A STUDY TO EVALUATE THE EFFECT OF TAGARADI GHANA VATI ON ANXIETY-RELATED SYMPTOMS SUCH AS FEAR, TENSION, INSOMNIA, AND EXCESSIVE WORRY IN ADOLESCENTS AGED 14 16 YEARS

EFFICACY OF TAGARADI GHANA VATI IN GENERALISED ANXIETY DISORDERS, CHITTODVEGA IN ADOLESCENT S OF AGE 14-16 YEARS A DOUBLE BLIND RANDOMIZED CONTROLLED TRIAL - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102634

Enrollment

Registered

2026-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children of either sex. 2. Children Aged between 14 and 16 years. 3. Children Who meet the DSM-5 TR diagnostic criteria for Generalised Anxiety Disorder (GAD).

Exclusion criteria

Exclusion criteria: 1. Children below 14 years or above 16 years of age. 2. Children currently undergoing psychological or psychiatric treatment. 3. Subjects presenting with anxiety symptoms secondary to trauma, surgery, or underlying organic lesions. 4. Children diagnosed with Neuro-behavioural disorders such as ADHD, Autism, Intellectual Disability, congenital disorders, developmental delays, or any autoimmune or genetic conditions. 5. Children with chronic illnesses or systemic disorders currently under treatment that may interfere with the outcome or continuity of the study.

Design outcomes

Primary

Measure	Time frame
Changes in symptoms of Generalised Anxiety Disorders among adolescents aged 14 16 years, using the Hamilton Anxiety Rating Scale HAM-A. Changes in the Mano Bhavas among adolescents aged 14 16 years with Generalised Anxiety Disorder, assessed through Manasa Pariksha Bhavas scale.Timepoint: 45 Days (30 days- Intervention Period, 15 days- Follow up)	—

Secondary

Measure	Time frame
Enhancement in sleep quality among adolescents aged 14 16 years with Generalised Anxiety Disorder, evaluated through the Insomnia Severity Index (ISI).Timepoint: 45 Days (30 days- Intervention Period, 15 days- Follow up);Improvement in quality of life among adolescents aged 14 16 years with Generalised Anxiety Disorder, as measured by the WHOQOL-BREF scale.Timepoint: 45 Days (30 days- Intervention Period, 15 days- Follow up);Reduction in severity of anxiety in adolescents aged 14 16 years with Generalised Anxiety Disorder, assessed using the GAD-7 scale.Timepoint: 45 Days (30 days- Intervention Period, 15 days- Follow up)	—

Measure

Time frame

Enhancement in sleep quality among adolescents aged 14 16 years with Generalised Anxiety Disorder, evaluated through the Insomnia Severity Index (ISI).Timepoint: 45 Days (30 days- Intervention Period, 15 days- Follow up);Improvement in quality of life among adolescents aged 14 16 years with Generalised Anxiety Disorder, as measured by the WHOQOL-BREF scale.Timepoint: 45 Days (30 days- Intervention Period, 15 days- Follow up);Reduction in severity of anxiety in adolescents aged 14 16 years with Generalised Anxiety Disorder, assessed using the GAD-7 scale.Timepoint: 45 Days (30 days- Intervention Period, 15 days- Follow up)

—

Countries

India

Contacts

Public ContactDr Kartik Honnalli

Sri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital, Bengaluru- 560074

drgirishkumargowda@gmail.com9449577136

Outcome results